Question 1

What is BMY stock price today?

Accepted Answer

Bristol-Myers Squibb Company (BMY) is currently trading at $58.13, up 2.99% today.

Question 2

What is BMY market cap?

Accepted Answer

Bristol-Myers Squibb Company has a market capitalization of $115 billion, making it one of the notable companies in the Healthcare sector.

Question 3

What is BMY P/E ratio?

Accepted Answer

Bristol-Myers Squibb Company has a P/E ratio of 16.33, which measures the stock price relative to its earnings per share.

Question 4

What is BMY price target?

Accepted Answer

The average analyst price target for Bristol-Myers Squibb Company is $54.00, which represents a -7.1% downside from the current price.

Question 5

What is BMY 52-week high and low?

Accepted Answer

Bristol-Myers Squibb Company's 52-week high is $62.89 and 52-week low is $42.52. The current price of $58.13 is 77% of its 52-week range.

Question 6

What do analysts say about BMY?

Accepted Answer

Analysts currently rate Bristol-Myers Squibb Company as Hold. Coverage is updated daily from major firms.

Question 7

Does BMY pay a dividend?

Accepted Answer

Yes, Bristol-Myers Squibb Company (BMY) pays a dividend with a current yield of 4.43%. This means for every $1,000 invested, you would receive approximately $44.29 per year in dividends.

Question 8

Is BMY revenue growing?

Accepted Answer

Bristol-Myers Squibb Company has a year-over-year revenue growth rate of +2.6%. Revenue is growing at a moderate pace.

Question 9

What sector is BMY in?

Accepted Answer

Bristol-Myers Squibb Company (BMY) operates in the Healthcare sector within the Drug Manufacturers - General industry. You can explore other stocks in this sector on our Healthcare sector page.

Question 10

How has BMY performed this year?

Accepted Answer

Bristol-Myers Squibb Company (BMY) has a year-to-date return of +4.6%. The stock has had a positive year so far.

Question 11

Is BMY overvalued or undervalued?

Accepted Answer

Bristol-Myers Squibb Company has a forward P/E ratio of 9.7 compared to its trailing P/E of 16.3. A lower forward P/E suggests analysts expect earnings growth. Visit the BMY stock page for detailed valuation analysis.

Bristol-Myers Squibb Company

Price chart

Price performance

The thesis at a glance

Who's buying BMY right now

Latest print - beat on both lines

10 analysts · 50% Buy

How BMY stacks vs Drug Manufacturers - General

Peers & themes